Explore the detailed record of transactions filed by SIMARD JOHN, Chairman & CEO. Officer active across 1 companies, notably XBiotech Inc.. Aggregated, 13 disclosures have been recorded. Total volume traded: €3.9m. The latest transaction was disclosed on 15 October 2021 (Cession). Regulator: SEC (Form 4). All data is openly available.
John Simard is Chief Executive Officer of XBiotech Inc. In this role, he oversees the company's operations and defines its overall strategy. Simard plays a key role in developing new treatments and innovation in the biotechnology field. His leadership is crucial for the growth of XBiotech.